Status:
UNKNOWN
Hallux Valgus Treatment Developed for Children With Cerebral Palsy
Lead Sponsor:
Istanbul Arel University
Conditions:
Hallux Valgus
Eligibility:
All Genders
117-201 years
Phase:
NA
Brief Summary
This study is a clinical trial.Hallux valgus, one of the common deformities in the foot in children with diplegic Cerebral Palsy, has caused serious problems in daily life activities in children and h...
Detailed Description
EXERCISE PROGRAM The Hallux Valgus exercise program determined by the physiotherapist will be performed twice a week in the rehabilitation unit accompanied by a physiotherapist, each exercise and mobi...
Eligibility Criteria
Inclusion
- Being diagnosed with cerebral palsy,
- Being a spastic diplegic type of cerebral palsy,
- Age range 9-16,
- Communication Function Classification System Level 1 and 2,
- Children with ambulatory level GMFCS 1-2,
- Using AFO and GRAFO,
- Children who do not use any assistive devices,
- Children with Manchester scale Stage 1 and 2 hallux valgus will be included in the study.
Exclusion
- Those who cannot walk independently,
- GMSCS 3 and above,
- Does not use AFO and GRAFO,
- Children using assistive devices,
- Communication Function Classification System Level 3 and above,
- Manchester scale stage 3 hallux valgus,
- Children with spasticity values above 1+ according to the Modified Ashworth Scale will be excluded from the study.
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06076655
Start Date
October 2 2023
End Date
January 1 2024
Last Update
October 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.